Regulation of caspase 3 and Fas in pressure overload-induced left ventricular dysfunction

European Journal of Heart Failure

Volumn 6, Issue 7, 2004, Pages 845-851

  Philipp, Sebastian ^a   Pagel, Ines ^a   Höhnel, Klaus ^a   Lutz, Jens ^b   Buttgereit, Jens ^a   Langenickel, Thomas ^a   Hamet, Pavel ^c   Dietz, Rainer ^a   Willenbrock, Roland ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Campus Hôtel Dieu   (Canada)

^d Sankt Elisabeth Hospital   (Germany)

Author keywords

Caspase; Fas; Heart; Left ventricular dysfunction; Left ventricular hypertrophy; Rat

Indexed keywords

CASPASE 3; FAS ANTIGEN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUOROMETRY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART WEIGHT; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; THORACIC AORTA; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD95; AORTA, THORACIC; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOTTING, WESTERN; CASPASE 3; CASPASES; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; HYPERTROPHY, LEFT VENTRICULAR; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STROKE VOLUME; UP-REGULATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 8844261202     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2004.01.014     Document Type: Article

References (28)

1. Li Z., Bing O.H.L., Long X., Robinson K.G., Lakatta E.G. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 272:1997;H2313-H2319
2. Narula J., Haider N., Virmani R., DiSalvo T., Kolodgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189
3. Condorelli G., Morisco C., Stassi G., Notte A., Farina F., Sgaramella G., et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation. 99:1999;3071-3078
4. Nitahara J.A., Cheng W., Liu Y., Li B., Leri A., Li P., et al. Intracellular Calcium, DNase activity and myocyte apoptosis in aging fischer 344 rats. J Mol Cell Cardiol. 30:1998;519-535
5. Teiger E., Dam T.-V., Richard L., Wisnewsky C., Tea B.-S., Gaboury L., et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 97:1996;2891-2897
6. Badorff C., Ruetten H., Mueller S., Stahmer M., Gehring D., Jung F., et al. Fas receptor signaling inhibits glycogen synthase kinase 3{beta} and induces cardiac hypertrophy following pressure overload. J Clin Invest. 109:2002;373-381
7. Wollert K.C., Heineke J., Westermann J., Ludde M., Fiedler B., Zierhut W., et al. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation. 101:2000;1172-1178
8. Hunter J.J., Chien K.R. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 341:1999;1276-1283
9. MacLellan W.R., Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144
10. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365
11. Chinnaiyan A.M., Dixit V.M. Portrait of an executioner: the molecular mechanism of Fas/ APO-1-induced apoptosis. Immunology. 9:1997;69-76
12. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA. 93:1996;14 486-14 491
13. Reed J.C. Warner-Lambert/Parke-Davis Award Lecture. Am J Pathol. 157:2000;1415-1430
14. Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 45:2000;528-537
15. Communal C., Sumandea M., deTombe P., Narula J., Solaro R.J., Hajjar R.J. Functional consequences of caspase activation in cardiac myocytes. PNAS. 99:2002;6252-6256
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159
17. Szabo A., Lutz J., Schleimer K., Antus B., Hamar P., Philipp T., et al. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int. 57:2000;982-991
18. Refaeli Y., vanParijs L., London C.A., Tschopp J., Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8:1998;615-623
19. + ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J Biol Chem. 274:1999;16 545-16 552
20. Katz A.M., Epstein F.H. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med. 322:1990;100-110
21. Capasso J.M., Palackal T., Olivetti G., Anversa P. Left ventricular failure induced by long-term hypertension in rat. Circ Res. 66:1990;1400-1412
22. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J.A., et al. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141
23. Hamet P., Moreau P., Dam T.-V., Orlov S.N., Tea B.-S., DeBlois D., et al. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling. J Hypertens. 14:1996;S65-S70
24. Kajstura J., Cheng W., Reiss K., Clark W.A., Sonnenblick E.H., Krajewski S., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107
25. Fortuno M.A., Ravassa S., Etayo J.C., Diez J. Over expression of bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats. Hypertension. 32:1998;280-286
26. Feldman A.M., Weinberg E.O., Ray P.E., Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 73:1993;184-192
27. Nishigaki K., Minatoguchi S., Seishima M., Asano K., Noda T., Yasuda N., et al. Plasma fas ligand,an inducer of apoptosis, and plasma soluble fas,an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 29:1997;1214-1220
28. Condorelli G., Roncarati R., Ross J., Pisani A., Stassi G., Todaro M., et al. Heart targeted over expression of caspase 3 in mice increases infarct size and depresses cardiac function. PNAS. 98:2001;9977-9982